229 related articles for article (PubMed ID: 2645963)
61. Epidemiological features of aplastic anaemia in Pakistan.
Adil SN; Burney IA; Kakepoto GN; Khurshid M
J Pak Med Assoc; 2001 Dec; 51(12):443-5. PubMed ID: 11850982
[TBL] [Abstract][Full Text] [Related]
62. Post-hepatitic aplastic anaemia in children in Taiwan, a hepatitis prevalent area.
Liang DC; Lin KH; Lin DT; Yang CP; Hung KL; Lin KS
Br J Haematol; 1990 Apr; 74(4):487-91. PubMed ID: 2346727
[TBL] [Abstract][Full Text] [Related]
63. Bone marrow histopathology of patients with severe aplastic anaemia before treatment and at follow-up.
de Planque MM; van Krieken JH; Kluin-Nelemans HC; Colla LP; van der Burgh F; Brand A; Kluin PM
Br J Haematol; 1989 Jul; 72(3):439-44. PubMed ID: 2788455
[TBL] [Abstract][Full Text] [Related]
64. Epigenetic and microenvironmental alterations in bone marrow associated with ROS in experimental aplastic anemia.
Chatterjee R; Law S
Eur J Cell Biol; 2018 Jan; 97(1):32-43. PubMed ID: 29173808
[TBL] [Abstract][Full Text] [Related]
65. Aetiological considerations of acquired aplastic anaemia.
Malik S; Sarwar I; Mehmood T; Naz F
J Ayub Med Coll Abbottabad; 2009; 21(3):127-30. PubMed ID: 20929030
[TBL] [Abstract][Full Text] [Related]
66. Aplastic anaemia following exposure to 3,4-methylenedioxymethamphetamine ('Ecstasy').
Marsh JC; Abboudi ZH; Gibson FM; Scopes J; Daly S; O'Shaunnessy DF; Baughan AS; Gordon-Smith EC
Br J Haematol; 1994 Oct; 88(2):281-5. PubMed ID: 7803271
[TBL] [Abstract][Full Text] [Related]
67. Pathophysiologic mechanisms in acquired aplastic anemia.
Young NS
Hematology Am Soc Hematol Educ Program; 2006; ():72-7. PubMed ID: 17124043
[TBL] [Abstract][Full Text] [Related]
68. Autoimmune aspects of aplastic anemia.
Baranski BG; Young NS
In Vivo; 1988; 2(1):91-4. PubMed ID: 2979824
[TBL] [Abstract][Full Text] [Related]
69. Persistent growth impairment of bone marrow stroma after antilymphocyte globulin treatment for severe aplastic anaemia and its association with relapse.
Nissen C; Wodnar-Filipowicz A; Slanicka Krieger MS; Slanicka Gratwohl A; Tichelli A; Speck B
Eur J Haematol; 1995 Oct; 55(4):255-61. PubMed ID: 7589344
[TBL] [Abstract][Full Text] [Related]
70. Drug-induced aplastic anaemia and agranulocytosis. Incidence and mechanisms.
Vincent PC
Drugs; 1986 Jan; 31(1):52-63. PubMed ID: 3940848
[TBL] [Abstract][Full Text] [Related]
71. The complex pathophysiology of acquired aplastic anaemia.
Zeng Y; Katsanis E
Clin Exp Immunol; 2015 Jun; 180(3):361-70. PubMed ID: 25683099
[TBL] [Abstract][Full Text] [Related]
72. Genomic insult oriented mitochondrial instability and proliferative hindrance in the bone marrow of aplastic mice including stem/progenitor population.
Chatterjee R; Law S
Pathol Res Pract; 2019 Apr; 215(4):784-793. PubMed ID: 30683472
[TBL] [Abstract][Full Text] [Related]
73. Granulocytic progenitor cells in aplastic anaemia.
Kern P; Heimpel H; Heit W; Kubanek B
Br J Haematol; 1977 Apr; 35(4):613-23. PubMed ID: 301399
[TBL] [Abstract][Full Text] [Related]
74. Epidemiology, Clinico-Haematological Profile and Management of Aplastic Anaemia: AIIMS Experience.
Mahapatra M; Singh PK; Agarwal M; Prabhu M; Mishra P; Seth T; Tyagi S; Patil HP; Saxena R
J Assoc Physicians India; 2015 Mar; 63(3 Suppl):30-5. PubMed ID: 26529865
[TBL] [Abstract][Full Text] [Related]
75. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.
Socié G; Henry-Amar M; Bacigalupo A; Hows J; Tichelli A; Ljungman P; McCann SR; Frickhofen N; Van't Veer-Korthof E; Gluckman E
N Engl J Med; 1993 Oct; 329(16):1152-7. PubMed ID: 8377778
[TBL] [Abstract][Full Text] [Related]
76. Aplastic anaemia with 'hot pockets'.
Kansu E; Erslev AJ
Scand J Haematol; 1976 Nov; 17(5):326-34. PubMed ID: 1034334
[TBL] [Abstract][Full Text] [Related]
77. Stimulatory serum factors in aplastic anaemia. II. Prognostic significance for patients treated with high dose immunosuppression.
Nissen C; Moser Y; Speck B; Gratwohl A; Weis J
Br J Haematol; 1985 Nov; 61(3):499-512. PubMed ID: 2415153
[TBL] [Abstract][Full Text] [Related]
78. Haemopoietic inhibitors in aplastic anaemia--a review.
Vincent PC
Pathology; 1982 Jan; 14(1):25-9. PubMed ID: 7043378
[No Abstract] [Full Text] [Related]
79. To determine the frequency of aldehyde dehydrogenase type 2 (aldh2) deficiency in aplastic anaemia: A single center experience from pakistan.
Shamim N; Khan MA; Iftikhar R; Akram Z; Jamshaid H; Rehman J; Chaudhry QUN; Ghafoor T
J Ayub Med Coll Abbottabad; 2023; 35(3):462-465. PubMed ID: 38404093
[TBL] [Abstract][Full Text] [Related]
80. Comparative study of bone marrow and blood plasma levels of IL-2 in aplastic anaemia and their relationship with disease severity.
De R; Dutta A; Dolai TK; Ghosh K; Halder A
Hematology; 2019 Dec; 24(1):84-88. PubMed ID: 30139310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
